![]() |
市場調查報告書
商品編碼
1825357
二氧化碳測量儀市場 - 預測 2025-2030Capnography Market - Forecasts from 2025 to 2030 |
二氧化碳測量儀市場預計將從 2025 年的 18.91 億美元成長到 2030 年的 29.77 億美元,複合年成長率為 9.50%。
二氧化碳測量儀市場趨勢
二氧化碳測量儀用於測量患者呼出氣體中二氧化碳的濃度或分壓。它是重症加護室、恢復室、病房和救護車等環境中必不可少的監測設備。作為一種非侵入性方法,它可以快速識別人工呼吸器故障、氣管插管位置不當和呼吸管路缺陷等呼吸問題。此技術以波形顯示呼出的二氧化碳,指示整個呼吸週期中的二氧化碳含量。
技術進步是二氧化碳測量儀市場的主要驅動力,使疾病檢測能夠更早、更有效率地進行。然而,由於脈搏血氧計等替代技術(該技術也可監測呼吸)的存在,以及二氧化碳測量儀在測量非插管患者呼吸頻率方面的不可靠性,市場成長面臨限制。
呼吸系統疾病(包括感染疾病、氣喘、肺癌和慢性阻塞性肺病(COPD))的盛行率在已開發國家和新興國家均呈現上升趨勢,持續推動市場擴張。這些慢性疾病會長期影響呼吸道和肺部結構,使呼吸道症狀成為初級保健就診的主要原因。吸菸仍然是導致盛行率上升的主要原因,而與吸菸相關的 COPD 在全球範圍內影響大量人口。
日間手術中心 (ASC) 提供的服務種類和數量正在急劇擴張,涵蓋了包括心臟病學在內的多個專科。即使是傳統的醫院內置換術,也正在轉向 ASC。這項轉變凸顯了門診病人在醫療保健服務中日益重要的角色。
技術創新的不斷推進、呼吸系統疾病盛行率的上升以及政府推廣先進監測技術的舉措,進一步推動了市場的成長。二氧化碳測量儀在病患監測中的應用日益廣泛,這得益於其在管理呼吸系統疾病方面的卓越可靠性和效率,從而改善了整體醫療保健效果。
二氧化碳測量儀市場細分分析
預計預測期內,二氧化碳測量儀在心臟護理中的應用將持續擴大,推動市場成長。這一快速成長的驅動力源於全球心血管疾病 (CVD) 盛行率的上升以及手術數量的增加。心血管疾病(例如 CVD、先天性心臟疾病(CHD) 和中風)是全球主要死因之一。據預測,到 2030 年,CVD 可能導致全球約 2,360 萬人死亡。值得注意的是,約 80% 的 CVD 相關死亡發生在非洲、拉丁美洲和亞太等中低收入地區。
加劇心血管疾病(CVD)發展的主要風險因素包括過量飲酒和吸煙、不良飲食習慣以及久坐不動的生活方式。這些因素導致心臟病發病率上升,並增加了循環系統科對二氧化碳測量儀設備的需求。這種情況可能導致死亡人數迅速增加,從而需要強大的監測工具,並進一步增加需求。
一個顯著的趨勢是,ASC 正轉向照護現場心臟護理服務,這進一步支持了二氧化碳測量儀的應用。隨著病患照護日益轉向門診病人,ASC 正逐漸成為傳統醫院經濟高效、高品質的替代方案。這一發展趨勢支持更廣泛的手術,包括心臟介入治療,二氧化碳測量儀可確保在手術和恢復期間進行即時呼吸監測。
總體而言,二氧化碳測量儀市場預計將持續成長,因其在應對呼吸和心臟挑戰方面發揮關鍵作用。儘管存在技術競爭,但其非侵入性特性和基於波形的競爭考察在關鍵臨床場景中具有顯著優勢。行業相關人員應密切關注與其他監測系統的整合進展以及監管支持,以抓住門診和重症患者監護領域的新興機會。強調插管患者的可靠性,並努力提高非插管病例的準確性,將是克服市場限制、擴大市場滲透率的關鍵。
本報告的主要優點
它有什麼用途?
產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響
The Capnography Market is expected to grow from USD 1.891 billion in 2025 to USD 2.977 billion in 2030, at a CAGR of 9.50%.
Capnography Market Trends
Capnography involves measuring the concentration or partial pressure of carbon dioxide in patients' exhaled breath. It serves as essential monitoring equipment in settings such as critical care, recovery rooms, wards, and ambulances. As a non-invasive method, it enables rapid identification of respiratory issues, including ventilator failure, tracheal tube malposition, and defective breathing circuits. The technology presents exhaled CO2 as a waveform, illustrating CO2 levels throughout the respiratory cycle.
Technological advancements are a primary driver of the capnography market, enabling earlier and more efficient disease detection. However, market growth faces limitations from alternative technologies like pulse oximetry, which also monitors respiration, and the unreliability of capnography for measuring respiratory rates in non-intubated patients.
The escalating prevalence of respiratory diseases-including infections, asthma, lung cancer, and chronic obstructive pulmonary disease (COPD)-in both developed and developing countries continues to propel market expansion. These chronic conditions affect airways and lung structures over extended periods, making respiratory symptoms a leading reason for primary care consultations. Smoking remains a key contributor to this rise, with COPD linked to tobacco use impacting significant populations worldwide.
Ambulatory surgical centers (ASCs) have seen substantial expansion in service types and volumes, encompassing diverse specialties like cardiology. Even fields traditionally hospital-based, such as spine and joint replacements, are increasingly shifting to ASCs. This transition underscores the growing role of outpatient settings in healthcare delivery.
Market growth is further supported by ongoing technological innovations, the rising incidence of respiratory diseases, and government initiatives promoting advanced monitoring. The increasing adoption of capnography for patient monitoring stems from its superior reliability and efficiency in managing respiratory conditions, enhancing overall medical outcomes.
Capnography Market Segmentation Analysis
The expanding applications of capnography in cardiac care are poised to drive market growth during the forecast period. This surge is fueled by the increasing prevalence of cardiovascular diseases (CVDs) and a growing volume of global surgeries. Heart conditions, including CVD, congenital heart disease (CHD), and stroke, rank among the top causes of mortality worldwide. Projections indicate that by 2030, CVDs could account for approximately 23.6 million deaths globally. Notably, around 80% of CVD-related deaths occur in low- and middle-income regions, such as Africa, Latin America, and Asia-Pacific.
Key risk factors exacerbating CVD incidence include excessive alcohol and tobacco consumption, poor dietary habits, and sedentary lifestyles. These elements contribute to rising heart disease rates, which in turn heighten the need for capnography devices in cardiology. The demand is amplified by the potential for rapid fatalities from these conditions, necessitating robust monitoring tools.
A notable trend is the shift toward point-of-care cardiac services in ASCs, which further boosts capnography adoption. As patient care increasingly moves to outpatient environments, ASCs emerge as cost-effective, high-quality alternatives to traditional hospitals. This evolution supports broader procedural scopes, including cardiac interventions, where capnography ensures real-time respiratory oversight during surgeries and recovery.
Overall, the capnography market is positioned for sustained growth, driven by its critical role in addressing respiratory and cardiac challenges. While technological alternatives pose competition, the device's non-invasive nature and waveform-based insights provide distinct advantages in high-stakes clinical scenarios. Industry stakeholders should monitor advancements in integration with other monitoring systems and regulatory support to capitalize on emerging opportunities in ambulatory and critical care settings. The focus on reliability for intubated patients, combined with efforts to improve accuracy for non-intubated cases, will be key to overcoming restraints and expanding market penetration.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Capnography Market Segmentation: